The global Electronic Data Capture systems market size was valued at USD 349.8 million in 2016. The increasing complexity in the management of clinical information generated before, during, and after the trial is expected to propel the demand for EDC system over the forecast period. The statistics published by the Center for Study of Drug Development states that more than 80% of clinical trials failed as they are unable to meet regulatory requirements, which resulted in delayed drug commercialization. This resulted in a loss of revenue for manufacturers. EDC systems help curb this problem by capturing & managing clinical information simply.
U.S. EDC systems market, by component, 2014 - 2025 (USD Million)
The companies are investing to implement eClinical solutions to manage clinical data because of the benefits attached to it, such as ease of use, integration of multiple functions, remote access to information, and cost-saving. The aforementioned factors are anticipated to boost the adoption of EDC in the coming years.
Services for the EDC systems held the largest market share as of 2016, owing to the availability of a large number of Contract Research Organizations (CROs) offering the eClinical solutions. This is due to the increasing scrutiny from regulatory bodies to meet the complex regulatory requirements of clinical trials, which is anticipated to contribute toward the growing demand over the forecast period.
The software segment is anticipated to witness lucrative growth soon due to rising adoption by manufacturers to curb growing expenditure on data management. The associated benefits of using EDC systems, such as timesaving and simpler regulatory processes, are presumed to boost the adoption in the coming years.
Depending on the current level of implementation and future growth prospects, cloud-based delivery systems for EDC services are expected to register the highest demand in near future. This exponential growth rate is a consequence of increasingly being recognized to provide greater efficiency in numerous applications, such as the trial design stage, data collection processes, and monitoring & report generation.
On the other hand, the web-based portal holds the largest share in the delivery mode segment, owing to the high data maintenance cost involved in clinical trials, which has increased dramatically. These high costs are presumed to contribute to the high reluctance of pharmaceutical companies, thus restricting them to invest in expensive studies and focus on relatively inexpensive alternatives for information management, such as web-based portals.
In the development phase segment, Phase III held a substantial share in 2016 owing to the high requirement for EDC software to curb the overall cost and improve the efficiency of processes. On the other hand, Phase I is presumed to grow with a lucrative growth rate soon as a consequence of the high significance of these systems in predicting future outcomes and eliminating drug candidates with a low probability of success in the clinical trials.
A large number of phase I trials and complex management and analysis processes of the information acquired during various studies have been boosting the demand for the computer-assisted solutions. The currently available tools have enabled minimization of manual errors and have increased the efficiency by cutting huge costs incurred through bypassing the processes of manual sourcing, transcribing, and double data entry. Direct data and remote information capturing are the factors aiding the rising popularity of these components during the forecast period. The integration of EDC systems is expected to result in a lowering of the prices for data management, which is anticipated to boost the market in the developing regions.
CROs held the largest market share and are anticipated to exhibit the fastest growth as a consequence of the rising inclination of pharmaceutical companies toward reducing overall expenditure and involved benefits, which are anticipated to be responsible for the heightened growth.
The benefits primarily include cost-effectiveness, increased efficiency of services, enhanced compatibility, and a higher focus on the core areas of development that are critical to a company's growth. Clinical information management involves clinical data processing by using a range of computer applications and support services.
Global EDC systems market share, by end-use, 2016 (%)
North America held the largest market share as of 2016 owing to the presence of higher awareness levels and stringent regulatory norms about the handling of clinical information. Besides, the presence of major pharmaceutical companies in this region is anticipated to boost the adoption of EDC systems over the forecast period.
Asia Pacific market for EDC systems is presumed to witness lucrative growth soon due to the presence of a large number of CROs offering eClinical solutions to large pharmaceutical companies.
Some of the key players operating in this industry are Medidata Solutions, Inc.; Oracle Corporation; BioClinica; Parexel International Corporation; Datatrak International, Inc.; Medidata Solutions, Inc.; eClinical Solutions; Merge Healthcare, Inc.; OmniComm Systems, Inc.; Acceliant; Clinipace, Inc.; and Openclinica, LLC.
Oracle Corporation and Medidata solutions are the most notable market players accounting for a considerable share of the market owing to their product offerings. Market leaders are involved in extensive research for the development of cost-effective and highly technologically advanced products. Subsequently, the introduction of such efficient products is expected to provide this industry with potential growth opportunities.
Report Attribute |
Details |
The market size value in 2020 |
USD 586.6 million |
The revenue forecast in 2025 |
USD 1.16 billion |
Growth Rate |
CAGR of 14.4% from 2017 to 2025 |
The base year for estimation |
2016 |
Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Component, delivery mode, development phase, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; UK; Germany; Japan; China; Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
Medidata Solutions, Inc.; Oracle Corporation; BioClinica; Parexel International Corporation; Datatrak International, Inc.; Medidata Solutions, Inc.; eClinical Solutions; Merge Healthcare, Inc.; OmniComm Systems, Inc.; Acceliant; Clinipace, Inc.; Openclinica, LLC |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the Electronic Data Capture Systems market based on the component, delivery mode, development phase, end-use, and region:
Software
Services
Web-hosted
Licensed enterprise
Cloud-based
Phase I
Phase II
Phase III
Phase IV
Hospitals
CROs
Academic institutes
Pharma & Biotech Organizations
Medical Device Manufacturers
North America
The U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Saudi Arabia
b. The global electronic data capture systems market size was estimated at USD 514.2 million in 2019 and is expected to reach USD 586.6 million in 2020.
b. The global electronic data capture systems market is expected to grow at a compound annual growth rate of 14.4% from 2019 to 2025 to reach USD 1,163.5 million by 2025.
b. North America dominated the electronic data capture systems market with a share of 52.31% in 2019. This is attributable to the higher awareness levels and stringent regulatory norms pertaining to the handling of clinical information coupled with the presence of major pharmaceutical companies.
b. Some key players operating in the electronic data capture systems market include Medidata Solutions, Inc.; Oracle Corporation; BioClinica; Parexel International Corporation; Datatrak International, Inc.; Medidata Solutions, Inc.; eClinicalSolutions; Merge Healthcare, Inc.; OmniComm Systems, Inc.; Acceliant; Clinipace, Inc.; and Openclinica, LLC.
b. Key factors that are driving the electronic data capture systems market growth are increasing complexity in management of clinical information generated before, during, and after the trial, cost-effectiveness, increased efficiency of services and enhanced compatibility.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."